IOVA Iovance Biotherapeutics, Inc. - Common Stock
$7,27
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$2–$7
100% of range
Ocena Analityków
BUY
15 analysts
Cena Docelowa
$9
+27% upside
P/E (TTM)
-6.7
ROE
-56.0%
Marża Zysku Netto
-148.4%
O Iovance Biotherapeutics, Inc. - Common Stock Przegląd firmy z Wikipedii
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
Czytaj więcej
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
## History
The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became Lion Bio Pharma, which was then rebranded to Iovance in 2017.
In 2024, the US FDA gave accelerated approval to Lifileucel, marketed under the brand name Amtagvi, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
IOVA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$7.27
Kapitalizacja Rynkowa
$2.99B
P/E (TTM)
-6.7
EPS (TTM)
$-1.09
Przychody (TTM)
$264M
Stopa dywidendy
—
ROE
-56.0%
D/E Dług/Kapitał
0.0
Zakres 52 tyg.
$2 – $7
IOVA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$264M
2016-12-31
→
2025-12-31
EPS
$-1.09
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-336M
2016-12-31
→
2025-12-31
Marże
-148.4%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
IOVA
Mediana porównawcza
P/E (TTM)
-6.7
—
P/S (TTM)
11.4
18.3
P/B
4.3
3.3
EV / EBITDA
-6.9
—
Price / FCF (Cena / FCF)
-8.9
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
IOVA
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-153.1%
—
Net Profit Margin (Marża Zysku Netto)
-148.4%
-180.4%
ROA
-42.9%
-36.2%
ROE
-56.0%
-43.7%
ROIC
-57.4%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
IOVA
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.0
—
Current Ratio (Wskaźnik bieżący)
3.2
9.7
Quick Ratio (Wskaźnik Szybkości)
2.7
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
IOVA
Mediana porównawcza
Revenue YoY (Przychody R/R)
60.6%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
IOVA
Mediana porównawcza
IOVA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
15 analityków
- Mocne kupno 3 20,0%
- Kup 9 60,0%
- Trzymaj 3 20,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
9 analityków · 2026-08-19
Mediana
$9.00
Teraz
$7.27
Niski
$4.00
Wysoki
$14.00
Średni cel
$9.00
+23,8%
Średnia cel
$9.22
+26,9%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.03%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.11 | $-0.13 | 0.02% |
| 31 marca 2026 | $-0.19 | $-0.15 | -0.04% |
| 31 grudnia 2025 | $-0.18 | $-0.18 | -0.00% |
| 30 września 2025 | $-0.25 | $-0.26 | 0.01% |
| 30 czerwca 2025 | $-0.33 | $-0.29 | -0.04% |
| 31 marca 2025 | $-0.36 | $-0.24 | -0.12% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264M | $164M | $1M | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $173M | $93M | $1M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $300M | $276M | $333M | $295M | $259M | $202M | $166M | $100M | $72M | $27M | $15M | $4M | |
| SG&A Expense | $152M | $152M | $106M | $104M | $84M | $60M | $41M | $28M | $21M | $27M | $12M | $8M | |
| Operating Expenses | $667M | $559M | $462M | $399M | $343M | $262M | $207M | $128M | $93M | $54M | $28M | $12M | |
| Operating Income | $-403M | $-395M | $-461M | $-399M | $-343M | $-262M | $-207M | $-128M | $-93M | $-54M | $-28M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $-5.7K | |
| Interest Income | $10M | $20M | $13M | $3M | $451.0K | $2M | $9M | $5M | $813.0K | $745.0K | $200.0K | $6.0K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $200.0K | $6.0K | |
| Pretax Income | $-393M | $-375M | $-448M | $-396M | $-342M | · | · | · | · | · | · | · | |
| Income Tax | $-2M | $-3M | $-3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| EPS (Basic) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| EPS (Diluted) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| Shares (Basic) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| Shares (Diluted) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| EBITDA | $-390M | $-383M | $-449M | $-390M | $-340M | $-261M | $-206M | $-128M | $-93M | $-54M | $-28M | · |
Bilans 28
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $116M | $115M | $232M | $78M | $67M | $14M | $82M | $145M | $107M | $34M | $45M | |
| Short-term Investments | $134M | $208M | $165M | $240M | $426M | $562M | $293M | $386M | $0 | $60M | $70M | $0 | |
| Receivables | $82M | $69M | $151.0K | · | · | · | · | · | · | · | · | · | |
| Inventory | $52M | $52M | $10M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $12M | $12M | $17M | $7M | $4M | $7M | $9M | $7M | $4M | $3M | $277.0K | $66.0K | |
| Current Assets | $443M | $457M | $308M | $479M | $508M | $636M | $316M | $475M | $149M | $170M | $104M | $45M | |
| PP&E (Net) | $131M | $109M | $114M | $105M | $101M | $59M | $9M | $3M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $180M | $145M | $142M | $122M | $110M | $65M | $13M | $7M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $49M | $36M | $28M | $17M | $9M | $6M | $4M | $4M | $3M | $2M | $1M | $104.0K | |
| Intangibles | $279M | $282M | $229M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $369.0K | $270.0K | $189.0K | $2M | $13M | $3M | $3M | $4M | $0 | · | · | |
| Total Assets | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Accounts Payable | $22M | $28M | $33M | $27M | $27M | $14M | $16M | $3M | $1M | $863.0K | $958.0K | $1M | |
| Accrued Liabilities | $111M | $82M | $69M | $52M | $57M | $35M | $16M | $12M | $8M | $4M | $672.0K | $328.0K | |
| Short-term Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $138M | $122M | $110M | $91M | $89M | $55M | $39M | $14M | $10M | $5M | $2M | $2M | |
| Capital Leases | $44M | $44M | $67M | $72M | $65M | $45M | $4M | $0 | · | · | · | · | |
| Deferred Tax | $32M | $32M | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $12M | $2M | $230.0K | · | · | · | · | |
| Total Liabilities | $215M | $200M | $196M | $164M | $156M | $112M | $46M | $15M | $10M | · | · | · | |
| Total Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $17.0K | $13.0K | $11.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $3.46B | $3.10B | $2.59B | $2.07B | $1.79B | $1.49B | $869M | $839M | $395M | $324M | $208M | $121M | |
| Retained Earnings | $-2.78B | $-2.38B | $-2.01B | $-1.57B | $-1.17B | $-830M | $-571M | $-373M | $-249M | $-157M | $-104M | $-77M | |
| AOCI | $16M | $-1M | $3M | $-902.0K | $-601.0K | $19.0K | $220.0K | $-42.0K | $0 | $29.0K | $48.0K | $0 | |
| Stockholders' Equity | $699M | $710M | $585M | $500M | $622M | $656M | $299M | $466M | $145M | $167M | $104M | $45M | |
| Liabilities + Equity | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Shares Outstanding | 411,938,061 | 305,252,194 | 256,135,715 | 187,812,072 | 157,004,742 | 147,874,917 | 126,411,808 | 123,415,576 | 73,164,914 | 62,248,074 | 48,547,720 | 33,750,188 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $11M | $12M | $9M | $3M | $1M | $1M | $956.0K | $952.0K | $978.0K | $999.0K | $88.0K | |
| Stock-based Comp | $62M | $110M | $63M | $84M | $70M | $41M | $24M | $20M | $12M | $19M | $9M | $4M | |
| Deferred Tax | $-2M | $-3M | $-3M | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $23M | $26M | $10M | $0 | · | · | · | · | · | · | · | · | |
| Restructuring | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $16M | $-100M | $12M | $10M | $41M | $12M | $13M | · | · | · | · | · | |
| Operating Cash Flow | $-302M | $-353M | $-362M | $-293M | $-228M | $-205M | $-159M | $-101M | $-79M | $-33M | $-18M | $-9M | |
| CapEx | $34M | $11M | $22M | $20M | $38M | $47M | $7M | $1M | $1M | $2M | $1M | $2M | |
| Investing Cash Flow | $47M | $-96M | $-155M | $256M | $132.0K | $-318M | $90M | $-386M | $59M | $9M | $-71M | · | |
| Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Stock Issued | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | $32M | |
| Net Stock Activity | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | · | |
| Financing Cash Flow | $301M | $391M | $463M | $190M | $239M | $576M | $6M | $424M | $59M | $97M | $78M | · | |
| Net Change in Cash | $47M | $-59M | $-57M | $154M | $11M | · | · | $-63M | $39M | $73M | $-11M | $25M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-336M | $-364M | $-384M | $-313M | $-266M | $-252M | $-166M | $-102M | $-80M | $-34M | $-20M | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -153.1% | -240.9% | -38735.0% | · | · | · | · | · | · | · | · | · | |
| Net Margin | -148.4% | -226.8% | -37345.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -149.2% | -228.6% | -37638.0% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -148.2% | -233.6% | -37762.1% | · | · | · | · | · | · | · | · | · | |
| ROA | -42.9% | -44.0% | -61.5% | -54.9% | -44.3% | -46.6% | -47.9% | -38.9% | -56.3% | -38.1% | -36.4% | · | |
| ROE | -56.0% | -50.2% | -70.6% | -88.6% | -51.9% | -37.9% | -60.4% | -34.3% | -58.9% | -39.0% | -37.2% | · | |
| ROIC | -57.4% | -55.2% | -78.2% | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 | 11.6 | 8.1 | 33.0 | 15.1 | 34.1 | 63.8 | · | |
| Quick Ratio | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 | 11.5 | 7.9 | 32.5 | 14.7 | 33.5 | 51.4 | · | |
| Debt / Equity | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.0 | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 3.4 | 4.0 | 2.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 4.7 | 15.7 | · | · | · | · | · | · | · | · | · |
Stopy Wzrostu 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.6% | 13699.0% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $264M | $164M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| Market Cap | $1.12B | $2.26B | $2.08B | $1.20B | $3.00B | $6.81B | $3.50B | $1.09B | $585M | $433M | $375M | · | |
| Enterprise Value | $829M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -5.8 | -4.3 | -2.6 | -8.6 | -24.7 | -17.4 | · | · | · | · | · | |
| P/S | 4.3 | 13.8 | 1751.4 | · | · | · | · | · | · | · | · | · | |
| P/B | 1.6 | 3.2 | 3.6 | 2.4 | 4.8 | 10.4 | 11.7 | 2.3 | 4.0 | 2.6 | 3.6 | · | |
| P / Tangible Book | 2.7 | 5.3 | 5.9 | 2.4 | 4.8 | 10.4 | · | · | · | · | · | · | |
| P / Cash Flow | -3.7 | -6.4 | -5.8 | -4.1 | -13.1 | -33.2 | -22.0 | -10.8 | -7.4 | -13.2 | -20.4 | · | |
| P / FCF | -3.3 | -6.2 | -5.4 | -3.8 | -11.3 | -27.1 | -21.1 | -10.7 | -7.3 | -12.7 | -19.2 | · | |
| EV / EBITDA | -2.1 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -2.5 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.9% | -17.3% | -23.2% | -39.0% | -11.7% | -4.0% | -5.7% | · | · | · | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99M | $71M | $87M | $67M | $60M | $49M | $74M | $59M | $31M | $715.0K | $482.0K | $469.0K | $238.0K | · | · | · | |
| Cost of Revenue | $44M | $42M | $28M | $38M | $49M | $43M | $23M | $32M | $31M | $7M | $-5M | $4M | $2M | · | · | · | |
| R&D Expense | $59M | $62M | $69M | $75M | $78M | $76M | $67M | $67M | $62M | $80M | $77M | $88M | $86M | $83M | $81M | $73M | |
| SG&A Expense | $39M | $39M | $36M | $35M | $38M | $44M | $42M | $39M | $40M | $31M | $29M | $27M | $22M | $28M | $26M | $28M | |
| Operating Expenses | $151M | $152M | $160M | $162M | $174M | $171M | $160M | $148M | $133M | $118M | $122M | $119M | $110M | $111M | $107M | $100M | |
| Operating Income | $-52M | $-81M | $-73M | $-95M | $-114M | $-121M | $-87M | $-89M | $-102M | $-118M | $-121M | $-118M | $-110M | $-111M | $-107M | $-100M | |
| Interest Income | $3M | $1M | $2M | $1M | $4M | $3M | $10M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $777.0K | |
| Pretax Income | $-49M | $-80M | $-72M | $-94M | $-110M | $-118M | $-77M | $-85M | $-99M | $-114M | $-118M | $-115M | $-107M | $-107M | $-105M | $-100M | |
| Income Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | · | |
| Net Income | $-47M | $-79M | $-72M | $-91M | $-112M | $-116M | $-79M | $-84M | $-97M | $-113M | $-116M | $-114M | $-107M | $-107M | $-105M | $-100M | |
| EPS (Basic) | $-0.11 | $-0.19 | $-0.15 | $-0.25 | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| EPS (Diluted) | $-0.11 | $-0.19 | · | · | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| Shares (Basic) | 450,189 | 418,511 | -664,071 | 364,037 | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| Shares (Diluted) | 450,189 | 418,511 | · | · | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| EBITDA | $-52M | $-78M | · | $-95M | $-110M | $-118M | · | $-86M | $-99M | $-115M | · | $-115M | $-107M | $-108M | · | $-100M |
Bilans 27
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $197M | $163M | $158M | $132M | $172M | $116M | $164M | $229M | $134M | $115M | $268M | $230M | $543M | $232M | $118M | |
| Short-term Investments | $187M | $117M | $134M | $143M | $169M | $188M | $208M | $233M | $184M | $222M | · | $94M | $21M | $83M | · | $242M | |
| Receivables | $102M | $82M | $82M | $67M | $60M | $71M | $69M | $56M | $32M | $234.0K | · | · | $33.0K | · | · | · | |
| Inventory | $56M | $58M | $52M | $52M | $50M | $66M | $52M | $39M | $28M | $18M | · | $9M | $10M | · | · | · | |
| Prepaid Expense | $9M | $13M | $12M | $10M | $12M | $16M | $12M | $7M | $10M | $11M | · | $12M | $14M | $11M | · | $10M | |
| Current Assets | $464M | $467M | $443M | $429M | $422M | $513M | $457M | $499M | $482M | $386M | · | $383M | $275M | $638M | · | $370M | |
| PP&E (Net) | $131M | $131M | $131M | $127M | $122M | $112M | $109M | $113M | $111M | $112M | · | $113M | $113M | $110M | · | $101M | |
| PP&E (Gross) | $188M | $184M | $180M | $172M | $165M | $150M | $145M | $149M | $145M | $143M | · | $138M | $135M | $129M | · | $115M | |
| Accum. Depreciation | $56M | $52M | $49M | $45M | $42M | $39M | $36M | $37M | $34M | $31M | · | $25M | $22M | $19M | · | $14M | |
| Intangibles | $264M | $269M | $279M | $285M | $296M | $285M | $282M | $307M | $295M | $294M | · | $224M | $236M | · | · | · | |
| Other Non-current Assets | $6M | $8M | $8M | $9M | $10M | $426.0K | $369.0K | $280.0K | $327.0K | $259.0K | · | $282.0K | $294.0K | $202.0K | · | $596.0K | |
| Total Assets | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Accounts Payable | $26M | $37M | $22M | $31M | $32M | $28M | $28M | $32M | $20M | $26M | · | $19M | $31M | $32M | · | $24M | |
| Accrued Liabilities | $78M | $88M | $111M | $87M | $89M | $85M | $82M | $75M | $62M | $46M | · | $61M | $47M | $43M | · | $48M | |
| Short-term Debt | · | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $107M | $129M | $138M | $126M | $129M | $123M | $122M | $118M | $94M | $83M | · | $91M | $89M | $87M | · | $79M | |
| Capital Leases | $43M | $44M | $44M | $45M | $45M | $44M | $44M | $66M | $69M | $72M | · | $68M | $69M | $70M | · | $72M | |
| Deferred Tax | $29M | $31M | $32M | $32M | $35M | $32M | $32M | $32M | $32M | $33M | · | $18M | $20M | · | · | · | |
| Total Liabilities | $179M | $204M | $215M | $203M | $209M | $199M | $200M | $218M | $196M | $190M | · | $178M | $179M | $158M | · | $152M | |
| Total Debt | · | $1M | · | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $18.0K | $17.0K | $16.0K | $14.0K | $14.0K | $13.0K | $13.0K | $12.0K | $12.0K | · | $11.0K | $9.0K | $9.0K | · | $7.0K | |
| Paid-in Capital | $3.62B | $3.56B | $3.46B | $3.39B | $3.29B | $3.26B | $3.10B | $3.06B | $2.99B | $2.81B | · | $2.58B | $2.36B | $2.34B | · | $1.86B | |
| Retained Earnings | $-2.90B | $-2.85B | $-2.78B | $-2.70B | $-2.61B | $-2.50B | $-2.38B | $-2.31B | $-2.22B | $-2.13B | · | $-1.90B | $-1.78B | $-1.68B | · | $-1.46B | |
| AOCI | $13M | $13M | $16M | $16M | $21M | $6M | $-1M | $16M | $526.0K | $116.0K | · | $-9M | $325.0K | $-126.0K | · | $-2M | |
| Stockholders' Equity | $736M | $722M | $699M | $702M | $698M | $768M | $710M | $773M | $769M | $680M | $585M | $674M | $579M | $667M | $500M | $394M | |
| Liabilities + Equity | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Shares Outstanding | 452,971,016 | 438,106,537 | 411,938,061 | 385,461,728 | 341,919,364 | 333,934,387 | 305,252,194 | 304,620,470 | 297,305,999 | 279,756,339 | · | 255,833,679 | 224,688,434 | 224,358,979 | · | 157,840,581 |
Przepływy pieniężne 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $12M | $11M | $12M | $12M | $15M | $23M | $31M | $31M | $30M | $17M | $14M | $16M | $17M | $16M | $20M | $20M | |
| Deferred Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | $0 | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $11M | $6M | $6M | $5M | $4M | $4M | $2M | $0 | · | $0 | |
| Restructuring | · | · | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-6M | · | · | · | $-11M | · | · | · | $-28M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $-61M | $-72M | $-53M | $-79M | $-67M | $-104M | $-73M | $-59M | $-98M | $-122M | $-84M | $-84M | $-94M | $-100M | $-78M | $-64M | |
| CapEx | $5M | $7M | $9M | $11M | $7M | $6M | $4M | $2M | $442.0K | $4M | $4M | $4M | $10M | $6M | $3M | $1M | |
| Investing Cash Flow | $-74M | $11M | $775.0K | $17M | $14M | $16M | $24M | $-49M | $40M | $-112M | $-73M | $-79M | $-157M | $153M | $461.0K | $74M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Issued | $50M | $99M | $56M | $89M | $13M | $149M | $0 | $48M | $152M | $198M | $1.0K | $203M | $0 | $260M | $190M | $0 | |
| Net Stock Activity | · | $99M | · | · | · | $149M | · | · | · | $198M | · | · | · | $260M | · | · | |
| Financing Cash Flow | $49M | $94M | $56M | $88M | $13M | $143M | $2M | $42M | $153M | $194M | $962.0K | $203M | $1M | $258M | $191M | $225.0K | |
| Net Change in Cash | $-86M | $33M | $5M | $26M | $-40M | $56M | $-48M | $-65M | $94M | $-41M | $-153M | $38M | $-253M | $312M | $113M | $10M | |
| Free Cash Flow | · | $-79M | · | · | · | $-110M | · | · | · | $-126M | · | · | · | $-105M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -52.3% | -113.5% | · | -140.7% | -189.8% | -245.8% | · | -152.1% | -327.6% | -16464.6% | · | -25236.9% | -46254.6% | · | · | · | |
| Net Margin | -47.6% | -110.7% | · | -135.3% | -186.2% | -235.5% | · | -142.7% | -312.2% | -15800.8% | · | -24255.9% | -44759.7% | · | · | · | |
| Pretax Margin | -49.0% | -111.6% | · | -138.8% | -182.9% | -239.2% | · | -145.3% | -316.8% | -15997.8% | · | -24520.9% | -44960.1% | · | · | · | |
| EBITDA Margin | -52.3% | -109.5% | · | -140.7% | -184.1% | -240.1% | · | -147.0% | -318.0% | -16048.1% | · | -24618.5% | -45036.1% | · | · | · | |
| ROA | -5.2% | -8.3% | · | -9.6% | -11.9% | -12.7% | · | -9.1% | -11.3% | -13.3% | · | -16.3% | -15.6% | -14.1% | · | -14.5% | |
| ROE | -6.6% | -10.6% | · | -12.4% | -15.2% | -16.1% | · | -11.5% | -14.4% | -16.8% | · | -21.3% | -20.3% | -17.6% | · | -18.2% | |
| ROIC | -6.9% | -11.1% | · | -13.2% | -16.6% | -15.5% | · | -11.3% | -13.1% | -17.1% | · | -17.4% | -18.9% | · | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 3.6 | · | 3.4 | 3.3 | 4.2 | · | 4.2 | 5.2 | 4.6 | · | 4.2 | 3.1 | 7.3 | · | 4.7 | |
| Quick Ratio | 3.7 | 3.1 | · | 2.9 | 2.8 | 3.5 | · | 3.8 | 4.7 | 4.3 | · | 4.0 | 2.8 | 7.2 | · | 4.5 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | 0.7 | · | 0.9 | 1.5 | 1.2 | · | 1.7 | 1.7 | 0.8 | · | 0.9 | 0.4 | · | · | · | |
| Receivables Turnover | 1.2 | 0.9 | · | 1.1 | 1.3 | 1.4 | · | 2.1 | 2.0 | 6.1 | · | · | 14.4 | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $298M | $248M | · | $235M | $199M | $140M | · | $91M | $33M | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-329M | $-398M | · | $-403M | $-408M | $-410M | · | $-407M | $-430M | $-441M | · | $-427M | $-413M | $-398M | · | $-377M | |
| Market Cap | $1.88B | $1.54B | · | $836M | $588M | $1.11B | · | $2.86B | $2.38B | $4.15B | · | $1.16B | $1.58B | $1.37B | · | $1.51B | |
| Enterprise Value | · | $1.23B | · | $537M | $288M | $753M | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | · | · | -1.7 | -1.3 | -2.4 | · | -6.3 | -4.7 | -8.0 | · | -2.2 | -3.2 | -2.6 | · | -4.0 | |
| P/S | 6.3 | 6.2 | · | 3.6 | 3.0 | 8.0 | · | 31.5 | 73.3 | · | · | · | · | · | · | · | |
| P/B | 2.6 | 2.1 | · | 1.2 | 0.8 | 1.4 | · | 3.7 | 3.1 | 6.1 | · | 1.7 | 2.7 | 2.1 | · | 3.8 | |
| P / Tangible Book | 4.0 | 3.4 | · | 2.0 | 1.5 | 2.3 | · | 6.1 | 5.0 | 10.7 | · | 2.6 | 4.6 | 2.1 | · | 3.8 | |
| P / Cash Flow | · | -21.3 | · | · | · | -10.7 | · | · | · | -33.9 | · | · | · | -13.7 | · | · | |
| P / FCF | · | -19.5 | · | · | · | -10.1 | · | · | · | -32.8 | · | · | · | -13.0 | · | · | |
| EV / EBITDA | · | -15.7 | · | -5.7 | -2.6 | -6.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -15.6 | · | · | · | -6.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 4.9 | · | 2.3 | 1.4 | 5.4 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | · | · | -60.4% | -76.2% | -42.0% | · | -16.0% | -21.1% | -12.5% | · | -45.3% | -31.7% | -38.3% | · | -24.9% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $264M | $164M | $1M | — | — |
| Marża Operacyjna % | -153.1% | -240.9% | -38735.0% | — | — |
| Zysk netto | $-391M | $-372M | $-444M | $-396M | $-342M |
| Rozwodniony EPS | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.0 | — | — | — | — |
| Wskaźnik bieżący | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 |
| Wskaźnik Szybkości | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-336M | $-364M | $-384M | $-313M | $-266M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Iovance Biotherapeutics (IOVA) rośnie o 43% po świetnym II kwartale. Co dalej?
- Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Small-Cap Stocks to Buy Now?
- Chardan Obniża Price Target IOVA, Utrzymuje Ocena Kupno
- Iovance Biotherapeutics Wyniki za I kwartał 2024 r.
- Analiza sentymentu pozostaje silna na temat Iovance Biotherapeutics (IOVA) w trakcie wdrożenia w USA leku na melanoma, Amtagvi
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 316 emitentów · $915.1M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 49 (-15 vs poprzedni kw.) | 35 (0 vs poprzedni kw.) | 124 (+7 vs poprzedni kw.) | 62 (-4 vs poprzedni kw.) | +44.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| MHR FUND MANAGEMENT LLC | $120 503 148 | 28 967 103 | 13,17% | Akcje |
| STATE STREET CORP | $101 829 595 | 24 478 268 | 11,13% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $79 084 500 | 19 010 697 | 8,64% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $75 729 672 | 18 204 248 | 8,28% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $59 858 236 | 14 388 999 | 6,54% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $36 971 836 | 8 885 825 | 4,04% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $35 467 823 | 8 525 919 | 3,88% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $24 866 629 | 5 977 555 | 2,72% | Akcje |
| Palo Alto Investors LP | $22 032 229 | 5 296 209 | 2,41% | Akcje |
| BANK OF AMERICA CORP /DE/ | $19 240 719 | 4 625 173 | 2,10% | Akcje |
| JUPITER ASSET MANAGEMENT LTD | $18 865 933 | 4 535 080 | 2,06% | Akcje |
| JANE STREET GROUP, LLC | $17 758 903 | 4 268 967 | 1,94% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13 393 769 | 3 219 656 | 1,46% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11 097 216 | 2 667 600 | 1,21% | Opcja kupna |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11 052 038 | 2 656 740 | 1,21% | Akcje |
| GOLDMAN SACHS GROUP INC | $10 683 579 | 2 568 168 | 1,17% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $10 578 372 | 2 542 878 | 1,16% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9 953 632 | 2 392 700 | 1,09% | Opcja sprzedaży |
| D. E. Shaw & Co., Inc. | $8 915 437 | 2 143 134 | 0,97% | Akcje |
| CITADEL ADVISORS LLC | $8 756 758 | 2 104 990 | 0,96% | Akcje |
| Long Focus Capital Management, LLC | $8 736 000 | 2 100 000 | 0,95% | Akcje |
| Orion Investment Co | $8 624 520 | 2 073 202 | 0,94% | Akcje |
| TWO SIGMA ADVISERS, LP | $8 230 950 | 3 015 000 | 0,90% | Akcje |
| Xcelsior Advisor Partners LLC | $7 421 124 | 1 783 924 | 0,81% | Akcje |
| Rhenman & Partners Asset Management AB | $7 094 160 | 1 705 327 | 0,78% | Akcje |
| Knott David M Jr | $6 656 000 | 1 600 000 | 0,73% | Akcje |
| RICE HALL JAMES & ASSOCIATES, LLC | $6 405 734 | 1 539 840 | 0,70% | Akcje |
| B Group, Inc. | $6 240 000 | 1 500 000 | 0,68% | Akcje |
| Invenomic Capital Management LP | $6 167 595 | 1 482 595 | 0,67% | Akcje |
| WELLS FARGO & COMPANY/MN | $5 994 285 | 1 440 934 | 0,66% | Akcje |
| VANGUARD GROUP INC | $5 760 305 | 2 110 002 | 0,63% | Akcje |
| Woodline Partners LP | $5 671 020 | 1 363 226 | 0,62% | Akcje |
| FMR LLC | $5 629 570 | 1 353 262 | 0,62% | Akcje |
| JPMORGAN CHASE & CO | $4 919 364 | 1 168 495 | 0,54% | Akcje |
| Mirador Capital Partners LP | $4 493 998 | 1 080 288 | 0,49% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $4 391 217 | 1 055 581 | 0,48% | Akcje |
| SECTOR GAMMA AS | $4 028 819 | 968 466 | 0,44% | Akcje |
| CITIGROUP INC | $3 574 126 | 859 165 | 0,39% | Akcje |
| CITADEL ADVISORS LLC | $3 385 824 | 813 900 | 0,37% | Opcja kupna |
| BlackRock, Inc. | $3 047 371 | 732 541 | 0,33% | Akcje |
| JANE STREET GROUP, LLC | $3 037 216 | 730 100 | 0,33% | Opcja kupna |
| CITADEL ADVISORS LLC | $2 996 864 | 720 400 | 0,33% | Opcja sprzedaży |
| Swiss National Bank | $2 922 633 | 702 556 | 0,32% | Akcje |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2 862 637 | 688 134 | 0,31% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $2 848 240 | 684 673 | 0,31% | Akcje |
| QVT Financial LP | $2 822 826 | 678 564 | 0,31% | Akcje |
| LPL Financial LLC | $2 750 070 | 661 075 | 0,30% | Akcje |
| 683 Capital Management, LLC | $2 680 288 | 644 300 | 0,29% | Opcja sprzedaży |
| RHUMBLINE ADVISERS | $2 471 712 | 594 164 | 0,27% | Akcje |
| Mariner, LLC | $2 101 647 | 505 190 | 0,23% | Akcje |
| ALGERT GLOBAL LLC | $1 975 746 | 474 939 | 0,22% | Akcje |
| CM Management, LLC | $1 872 000 | 450 000 | 0,20% | Akcje |
| Bank of New York Mellon Corp | $1 855 065 | 445 929 | 0,20% | Akcje |
| Rafferty Asset Management, LLC | $1 675 981 | 402 880 | 0,18% | Akcje |
| Raiffeisen Bank International AG | $1 599 800 | 380 000 | 0,17% | Akcje |
| Cresset Asset Management, LLC | $1 596 550 | 383 786 | 0,17% | Akcje |
| Balyasny Asset Management L.P. | $1 552 861 | 373 284 | 0,17% | Akcje |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $1 539 200 | 370 000 | 0,17% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $1 477 850 | 421 040 | 0,16% | Akcje |
| JANE STREET GROUP, LLC | $1 436 032 | 345 200 | 0,16% | Opcja sprzedaży |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1 420 778 | 404 780 | 0,16% | Akcje |
| Squarepoint Ops LLC | $1 354 421 | 325 582 | 0,15% | Akcje |
| Kennondale Capital Management LLC | $1 323 662 | 318 188 | 0,14% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $1 222 994 | 293 989 | 0,13% | Akcje |
| IEQ CAPITAL, LLC | $1 218 722 | 292 962 | 0,13% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 186 078 | 285 115 | 0,13% | Akcje |
| Virtus Investment Advisers, LLC | $1 185 683 | 285 020 | 0,13% | Akcje |
| Creative Planning | $1 171 914 | 281 710 | 0,13% | Akcje |
| Quadrature Capital Ltd | $1 160 378 | 278 937 | 0,13% | Akcje |
| MORGAN STANLEY | $1 142 544 | 274 650 | 0,12% | Akcje |
| ExodusPoint Capital Management, LP | $1 125 925 | 270 655 | 0,12% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1 090 532 | 262 147 | 0,12% | Akcje |
| Man Group plc | $1 052 309 | 252 959 | 0,11% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 036 826 | 295 392 | 0,11% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 025 353 | 246 479 | 0,11% | Akcje |
| TD Asset Management Inc | $1 019 416 | 245 052 | 0,11% | Akcje |
| GROUP ONE TRADING LLC | $988 711 | 237 671 | 0,11% | Akcje |
| MetLife Investment Management, LLC | $965 748 | 232 151 | 0,11% | Akcje |
| UBS Group AG | $952 890 | 229 060 | 0,10% | Akcje |
| Baird Financial Group, Inc. | $924 934 | 222 340 | 0,10% | Akcje |
| Walleye Capital LLC | $923 104 | 221 900 | 0,10% | Opcja kupna |
| Vanguard Global Advisers, LLC | $900 228 | 216 401 | 0,10% | Akcje |
| PROFUND ADVISORS LLC | $849 530 | 204 214 | 0,09% | Akcje |
| Parametrica Management Ltd | $814 852 | 195 878 | 0,09% | Akcje |
| Engineers Gate Manager LP | $790 546 | 190 035 | 0,09% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $762 349 | 183 257 | 0,08% | Akcje |
| Invesco Ltd. | $657 292 | 158 003 | 0,07% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $646 872 | 155 498 | 0,07% | Akcje |
| OSAIC HOLDINGS, INC. | $635 207 | 152 695 | 0,07% | Akcje |
| Intellectus Partners, LLC | $631 677 | 151 846 | 0,07% | Akcje |
| Leonteq Securities AG | $624 000 | 150 000 | 0,07% | Akcje |
| Soleus Capital Management, L.P. | $624 000 | 150 000 | 0,07% | Akcje |
| ADAR1 Capital Management, LLC | $607 734 | 146 090 | 0,07% | Akcje |
| Headlands Technologies LLC | $577 570 | 138 839 | 0,06% | Akcje |
| Sugar Maple Asset Management, LLC | $561 600 | 135 000 | 0,06% | Akcje |
| PORTLAND INVESTMENT COUNSEL INC. | $540 800 | 130 000 | 0,06% | Akcje |
| SIMPLEX TRADING, LLC | $524 605 | 126 107 | 0,06% | Akcje |
| JANUS HENDERSON GROUP PLC | $497 977 | 141 672 | 0,05% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $488 292 | 117 378 | 0,05% | Akcje |
| BARCLAYS PLC | $482 759 | 116 048 | 0,05% | Akcje |
Insiderzy spółki 37 insiderów · 9 dyrektorzy generalni · 14 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Frederick G Vogt | Interim CEO & General Counsel | 5 czerwca 2026 M | 562 492 | 0 | 0 | $0 |
| Maria Fardis | President and CEO | 4 stycznia 2021 A | 298 786 | 0 | 0 | $0 |
| Paul Kessler | Chair,CEO, Pres., Pr.Acctg | 24 lipca 2013 A | 15 693 215 | 0 | 0 | $0 |
| Jean-Marc Bellemin | Chief Financial Officer | 2 czerwca 2025 M | 60 529 | 0 | 0 | $0 |
| Timothy E Morris | Chief Financial Officer | 4 marca 2019 A | — | 0 | 0 | $0 |
| Igor Bilinsky | Chief Operating Officer | 5 czerwca 2026 M | 133 920 | 0 | 0 | $0 |
| Raj K. Puri | Chief Regulatory Officer | 16 czerwca 2026 A | 248 114 | 0 | 0 | $0 |
| Finckenstein Friedrich Graf | Chief Medical Officer | 5 czerwca 2026 M | 140 111 | 0 | 0 | $0 |
| Michael Swartzburg | Vice President, Finance (PAO) | 4 stycznia 2021 A | — | 0 | 0 | $0 |
| Iain D. Dukes | Dyrektor | 16 czerwca 2026 A | 54 000 | 0 | 0 | $0 |
| Athena Countouriotis | Dyrektor | 16 czerwca 2026 A | — | 0 | 0 | $0 |
| Ryan D Maynard | Dyrektor | 16 czerwca 2026 A | 7 500 | 0 | 0 | $0 |
| Michael Weiser | Dyrektor | 16 czerwca 2026 A | 112 632 | 0 | 0 | $0 |
| Wendy L Yarno | Dyrektor | 13 czerwca 2025 A | — | 0 | 0 | $0 |
| Wayne P. Rothbaum | Dyrektor | 1 marca 2024 A | 28 067 333 | 0 | 0 | $0 |
| Merrill A Mcpeak | Dyrektor | 1 marca 2024 A | 320 150 | 0 | 0 | $0 |
| Wendy L Dixon | Dyrektor | 10 czerwca 2022 A | — | 0 | 0 | $0 |
| Ayer Capital Management, LP | Dyrektor | 22 maja 2013 C | 560 401 150 | 0 | 0 | $0 |
| Martin Schroeder | Dyrektor | 22 sierpnia 2011 P | 1 000 000 | 0 | 0 | $0 |
| Mark J Ahn | Dyrektor | 26 maja 2010 A | — | 0 | 0 | $0 |
| Bristol Investment Fund, Ltd. | Posiadacz 10% | 6 listopada 2014 S | 3 867 863 | 0 | 0 | $0 |
| Hamilton Atlantic | Posiadacz 10% | 31 marca 2010 J | 0 | 0 | 0 | $0 |
| Daniel Gordon Kirby | — | 10 sierpnia 2026 M | 154 511 | 0 | 0 | $0 |
| Corleen M. Roche | — | 6 sierpnia 2026 M | 28 757 | 0 | 0 | $0 |
| Jay Venkatesan | — | 1 czerwca 2017 A | — | 0 | 0 | $0 |
| Sanford Hillsberg | — | 1 czerwca 2017 A | 100 000 | 0 | 0 | $0 |
| Gregory T Schiffman | — | 14 listopada 2016 A | — | 0 | 0 | $0 |
| Molly Henderson | — | 10 czerwca 2016 A | — | 0 | 0 | $0 |
| Michael Lotze | — | 28 marca 2016 A | — | 0 | 0 | $0 |
| James G. Bender | — | 11 marca 2016 A | 88 726 | 0 | 0 | $0 |
| Elma Hawkins | — | 11 marca 2016 A | 176 567 | 0 | 0 | $0 |
| Steven A. Fischkoff | — | 4 lutego 2016 A | — | 0 | 0 | $0 |
| Laszlo Radvanyi | — | 5 grudnia 2014 A | 180 000 | 0 | 0 | $0 |
| Michael D Handelman | — | 5 grudnia 2014 A | — | 0 | 0 | $0 |
| Manish Singh | — | 30 grudnia 2013 A | 2 546 000 | 0 | 0 | $0 |
| Richard Mckilligan | — | 29 marca 2011 J | 1 220 016 | 0 | 0 | $0 |
| Robert T. Brooke | — | 25 marca 2011 J | 4 440 008 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 6 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Quogue Capital LLC, Wayne P. Rothbaum ×5 zgłoszenia | 19 marca 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 11 lutego 2015 | — | Pierwotne zgłoszenie | — | SEC |
| Bristol Investment Fund, Ltd., Bristol Capital, LLC ×4 zgłoszenia | 20 lutego 2014 | — | Pierwotne zgłoszenie | — | SEC |
| Robert T. Brooke ×2 zgłoszenia | 12 maja 2011 | — | Pierwotne zgłoszenie | — | SEC |
| Hamilton Atlantic | 5 listopada 2010 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Niezgłoszona osoba raportująca | 29 marca 2010 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 49 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IDNA · iShares Trust | 2,65% | 841 830 SH | 8 sierpnia 2026 | Dziennie |
| BBP · ETFis Series Trust I | 2,44% | 430 167 NS | 30 kwietnia 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,77% | 27 306 SH | 8 sierpnia 2026 | Dziennie |
| CANC · Tema ETF Trust | 0,65% | 280 048 NS | 31 maja 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,30% | 466 051 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 1 035 381 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,19% | 24 302 SH | 8 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,19% | 2 852 725 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,16% | 3 686 426 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 346 628 SH | 8 sierpnia 2026 | Dziennie |
| GINN · Goldman Sachs ETF Trust | 0,09% | 45 126 NS | 31 maja 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,09% | 6 714 NS | 31 maja 2026 | N-PORT |
| BIB · ProShares Trust | 0,08% | 15 232 NS | 31 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,08% | 10 143 030 SH | 8 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,07% | 76 919 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 452 513 NS | 31 maja 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 261 797 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 2 290 247 SH | 8 sierpnia 2026 | Dziennie |
| TECB · iShares Trust | 0,05% | 38 134 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,04% | 1 472 303 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 15 876 NS | 31 maja 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 146 249 NS | 30 kwietnia 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 15 580 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 1 615 534 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 12 416 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 4 303 944 SH | 8 sierpnia 2026 | Dziennie |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 3 089 380 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,02% | 1 053 780 SH | 8 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,02% | 21 537 SH | 8 sierpnia 2026 | Dziennie |
| TMFE · RBB Fund, Inc. | 0,02% | 3 704 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 140 923 NS | 30 kwietnia 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 18 065 NS | 30 kwietnia 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 12 558 NS | 31 maja 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 71 148 NS | 30 kwietnia 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,01% | 4 849 607 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12 045 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 315 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 44 207 NS | 30 kwietnia 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 125 344 NS | 31 maja 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 146 278 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 482 457 NS | 30 kwietnia 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 510 986 SH | 8 sierpnia 2026 | Dziennie |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 89 379 NS | 31 maja 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 16 834 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 128 547 NS | 30 kwietnia 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 224 829 NS | 31 maja 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 64 557 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 13 489 795 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 32 806 SH | 8 sierpnia 2026 | Dziennie |